Is Sleep Apnea Genetic? What Your DNA Says About Obstructive Sleep Apnea

Obstructive sleep apnea (OSA) affects nearly one billion people worldwide, yet most cases remain undiagnosed (Benjafield et al., 2019). The conventional narrative focuses on obesity and aging as the primary drivers, and while those factors are important, they do not explain the full picture. Family studies consistently show that OSA clusters in families independent of body weight. Twin and family aggregation studies estimate the heritability of the apnea-hypopnea index (AHI), the standard measure of sleep apnea severity, at approximately 40% (Redline et al., 1995; Carmelli et al., 2004).

If your parent or sibling has sleep apnea, your own risk is roughly two to four times higher than the general population (Redline et al., 1995). The genetics behind this elevated risk involve a complex interplay between craniofacial structure, body fat distribution, ventilatory control, and airway muscle tone.

Two Types of Sleep Apnea: Different Genetic Paths

Before diving into specific genes, it helps to distinguish the two main forms.

Obstructive sleep apnea occurs when the upper airway physically collapses during sleep, blocking airflow despite continued respiratory effort. This is by far the more common type, accounting for over 80% of cases (Peppard et al., 2013).

Central sleep apnea involves a failure of the brainstem to send proper signals to the breathing muscles. The airway may remain open, but the drive to breathe temporarily shuts down. Central sleep apnea is rarer and has a distinct genetic signature, most notably involving the PHOX2B gene (Amiel et al., 2003).

Both types can coexist in the same individual, a condition called complex or treatment-emergent sleep apnea.

Key Genes and Genetic Factors

PHOX2B and Central Sleep Apnea

PHOX2B encodes a transcription factor critical for the development of the autonomic nervous system, including the brainstem circuits that control breathing. Key details:

• CCHS: Polyalanine expansion mutations in PHOX2B cause congenital central hypoventilation syndrome, a rare but serious condition in which the brain fails to regulate breathing properly during sleep (Amiel et al., 2003)
• Penetrance: Expansions of 25 or more repeats (normal is 20) are associated with increasingly severe phenotypes, including the need for lifelong ventilatory support (Berry-Kravis et al., 2006)
• Broader relevance: Subtler PHOX2B variants may contribute to central apnea susceptibility in the general population, though research in this area is still emerging (Rand et al., 2011)
• Autonomic dysfunction: PHOX2B mutations also cause broader autonomic dysregulation, including impaired heart rate variability and blood pressure control during sleep (Weese-Mayer et al., 2010)

Craniofacial Anatomy Genes

The size and shape of your jaw, tongue, palate, and pharyngeal airway are strongly influenced by genetics. A narrow maxilla, retrognathic (recessed) mandible, or enlarged tongue all reduce the space available for airflow and increase collapse risk during sleep (Chi et al., 2011).

• GWAS discoveries: A 2019 multi-ethnic study identified novel loci on chromosomes 2, 8, and 18 associated with AHI, with several mapping near genes involved in facial and pharyngeal development (Cade et al., 2016)
• PAX and SOX gene families: These transcription factor families regulate craniofacial morphogenesis; variants may influence jaw size and airway dimensions (Weinberg et al., 2013)
• Lean OSA in East Asians: Craniofacial structure rather than obesity is often the dominant predisposing factor in East Asian populations, where OSA prevalence is high despite lower average BMI (Li et al., 2000)
• Heritability of craniofacial traits: Cephalometric measures relevant to OSA, such as posterior airway space and mandibular length, are 50 to 80% heritable (Johannsdottir et al., 2005)

FTO and Obesity-Related Loci

The FTO gene is the strongest common genetic determinant of body mass index. Each risk allele at the FTO locus is associated with approximately 1 to 1.5 kg of additional body weight on average (Frayling et al., 2007). Because obesity is the single largest modifiable risk factor for OSA, FTO variants contribute to sleep apnea risk indirectly through their effect on weight.

Beyond total body mass, fat distribution matters enormously:

• Neck circumference: Fat deposition around the upper airway directly compresses the pharynx; neck circumference greater than 43 cm in men is a strong OSA predictor (Davies & Stradling, 1990)
• Visceral fat: Variants near IRS1 and GRB14 influence regional adiposity and may affect sleep apnea risk independent of overall BMI (Shungin et al., 2015)
• Tongue fat: MRI studies have shown that tongue fat volume is increased in OSA patients and correlates with disease severity (Kim et al., 2014)
• Weight loss impact: A 10% reduction in body weight can improve AHI by approximately 26% in obese OSA patients (Peppard et al., 2000)

Ventilatory Control and Arousal Threshold Genes

The tendency to wake up (or not) in response to airway obstruction is itself heritable. Some individuals have a low arousal threshold, waking at the slightest obstruction, which paradoxically worsens sleep fragmentation. Others maintain a high arousal threshold, allowing longer apneas but more stable sleep architecture (Eckert et al., 2013).

• Serotonin receptor genes: Variants in HTR2A and HTR3B have been implicated in upper airway dilator muscle tone and ventilatory drive during sleep (Bayazit et al., 2006)
• Hypoxic chemosensitivity: Individual differences in the carotid body response to low oxygen are heritable and influence loop gain, a key physiological trait in OSA pathogenesis (Wellman et al., 2011)
• Loop gain: High loop gain (an oversensitive ventilatory control system) promotes respiratory instability during sleep; this trait shows significant familial aggregation (Terrill et al., 2015)

Gene-Environment Interactions

Genetics loads the gun, but environment often pulls the trigger. Several factors interact powerfully with genetic predisposition:

• Obesity amplification: A person with both craniofacial risk variants and high FTO-related obesity susceptibility faces a compounded risk that far exceeds either factor alone. Weight gain in genetically susceptible individuals can transform mild snoring into severe OSA within a few years (Young et al., 2002)
• Alcohol and sedatives: These substances relax upper airway muscles, increasing collapsibility. Individuals with a genetically narrow airway may tolerate alcohol poorly in terms of sleep-disordered breathing, even if they show no problems while sober (Issa & Sullivan, 1982)
• Aging: Loss of muscle tone in the pharyngeal dilator muscles accelerates with age. Genetic variants influencing muscle fiber composition may determine how rapidly this decline occurs (Eikermann et al., 2007)
• Sleep position: Supine sleeping worsens OSA due to gravitational effects on the tongue and soft palate. This positional component interacts with craniofacial genetics in predictable ways (Joosten et al., 2014)
• Smoking: Current smokers have a roughly threefold higher risk of OSA compared to never-smokers, likely through airway inflammation and edema (Wetter et al., 1994)

Clinical Implications of Genetic Risk Profiling

Understanding the genetic basis of your sleep apnea can inform treatment decisions beyond the standard CPAP machine:

• Craniofacial-driven OSA may respond better to mandibular advancement devices or maxillomandibular advancement surgery than to weight loss alone (Sutherland et al., 2014)
• Obesity-driven OSA benefits most from weight management, with bariatric surgery reducing AHI by 60 to 80% in severe cases (Greenburg et al., 2009)
• Central apnea with PHOX2B involvement requires different therapeutic approaches, including adaptive servo-ventilation rather than standard CPAP (Aurora et al., 2012)
• Low arousal threshold phenotypes may benefit from targeted pharmacotherapy with agents like trazodone or zopiclone that stabilize sleep without worsening obstruction (Edwards et al., 2013)
• High loop gain phenotypes may respond to acetazolamide or supplemental oxygen (Edwards et al., 2012)

Health Consequences of Untreated OSA

The stakes of undiagnosed sleep apnea extend far beyond daytime sleepiness:

• Cardiovascular risk: Severe untreated OSA increases the risk of hypertension by threefold, and is independently associated with atrial fibrillation, heart failure, and stroke (Marin et al., 2005)
• Metabolic effects: OSA worsens insulin resistance and is linked to a 30% higher risk of type 2 diabetes (Kendzerska et al., 2014)
• Motor vehicle accidents: Untreated OSA patients have a two to threefold higher crash risk due to excessive daytime sleepiness (Tregear et al., 2009)
• Cognitive decline: Chronic intermittent hypoxia from OSA accelerates age-related cognitive decline and may increase Alzheimer's disease risk (Osorio et al., 2015)

Key Takeaways

• Sleep apnea is approximately 40% heritable, with genetics influencing craniofacial structure, obesity tendency, ventilatory control, and arousal threshold
• PHOX2B mutations cause central sleep apnea through impaired brainstem respiratory drive
• Craniofacial anatomy is 50 to 80% heritable and explains why many lean individuals develop OSA
• FTO and other obesity-related loci contribute to OSA indirectly through body weight and fat distribution
• Gene-environment interactions mean that alcohol, sleep position, and weight gain have amplified effects in genetically susceptible people
• Identifying the dominant pathophysiological trait (anatomy, obesity, arousal threshold, or loop gain) enables precision treatment selection
• Untreated OSA carries serious cardiovascular, metabolic, and cognitive risks

Uncover Your Sleep Apnea Risk With GenomeInsight

Sleep apnea steals your rest, your energy, and your long-term cardiovascular health. GenomeInsight examines your genetic data for the key variants that influence airway anatomy, body composition, and respiratory control to provide a comprehensive sleep apnea risk assessment. Upload your DNA data now to get started, learn more about our methodology, or sign up for our newsletter to stay informed on the latest genomic sleep research.

References

Amiel, J., Laudier, B., Attié-Bitach, T., Trang, H., de Pontual, L., Vekemans, M., ... & Lyonnet, S. (2003). Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nature Genetics, 33(4), 459-461. https://doi.org/10.1038/ng1130

Aurora, R. N., Chowdhuri, S., Ramar, K., Bista, S. R., Casey, K. R., Lamm, C. I., ... & Tracy, S. L. (2012). The treatment of central sleep apnea syndromes in adults. Sleep, 35(1), 17-40. https://doi.org/10.5665/sleep.1580

Bayazit, Y. A., Yilmaz, M., Ciftci, T. U., Erdal, M. E., Kokturk, O., Gokdogan, T., ... & Inal, E. (2006). Association of the -1438G/A polymorphism of the 5-HT2A receptor gene with obstructive sleep apnea syndrome. ORL, 68(3), 123-128. https://doi.org/10.1159/000091090

Benjafield, A. V., Ayas, N. T., Eastwood, P. R., Heinzer, R., Ip, M. S. M., Morrell, M. J., ... & Malhotra, A. (2019). Estimation of the global prevalence and burden of obstructive sleep apnoea: A literature-based analysis. The Lancet Respiratory Medicine, 7(8), 687-698. https://doi.org/10.1016/S2213-2600(19)30198-5

Berry-Kravis, E. M., Zhou, L., Rand, C. M., & Weese-Mayer, D. E. (2006). Congenital central hypoventilation syndrome: PHOX2B mutations and phenotype. American Journal of Respiratory and Critical Care Medicine, 174(10), 1139-1144. https://doi.org/10.1164/rccm.200602-305OC

Cade, B. E., Chen, H., Stilp, A. M., Gleason, K. J., Sofer, T., Ancoli-Israel, S., ... & Redline, S. (2016). Genetic associations with obstructive sleep apnea traits in Hispanic/Latino Americans. American Journal of Respiratory and Critical Care Medicine, 194(7), 886-897. https://doi.org/10.1164/rccm.201512-2431OC

Carmelli, D., Bliwise, D. L., Swan, G. E., & Reed, T. (2004). Genetic factors in self-reported snoring and excessive daytime sleepiness: A twin study. American Journal of Respiratory and Critical Care Medicine, 170(12), 1354-1357. https://doi.org/10.1164/rccm.200405-602OC

Chi, L., Comyn, F. L., Mitra, N., Reber, M. P., Maislin, G., Gobien, R. P., ... & Schwab, R. J. (2011). Identification of craniofacial risk factors for obstructive sleep apnoea using three-dimensional MRI. European Respiratory Journal, 38(2), 348-358. https://doi.org/10.1183/09031936.00119210

Davies, R. J., & Stradling, J. R. (1990). The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apnoea syndrome. European Respiratory Journal, 3(5), 509-514.

Eckert, D. J., White, D. P., Jordan, A. S., Malhotra, A., & Wellman, A. (2013). Defining phenotypic causes of obstructive sleep apnea: Identification of novel therapeutic targets. American Journal of Respiratory and Critical Care Medicine, 188(8), 996-1004. https://doi.org/10.1164/rccm.201303-0448OC

Edwards, B. A., Sands, S. A., Eckert, D. J., White, D. P., Butler, J. P., Owens, R. L., ... & Wellman, A. (2012). Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea. Journal of Physiology, 590(5), 1199-1211. https://doi.org/10.1113/jphysiol.2011.223925

Edwards, B. A., Eckert, D. J., McSharry, D. G., Sands, S. A., Desai, A., Kehlmann, G., ... & Wellman, A. (2013). Clinical predictors of the respiratory arousal threshold in patients with obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine, 190(11), 1293-1300. https://doi.org/10.1164/rccm.201404-0718OC

Eikermann, M., Jordan, A. S., Chamberlin, N. L., Gautam, S., Wellman, A., Lo, Y. L., ... & Malhotra, A. (2007). The influence of aging on pharyngeal collapsibility during sleep. Chest, 131(6), 1702-1709. https://doi.org/10.1378/chest.06-2653

Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M., ... & McCarthy, M. I. (2007). A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science, 316(5826), 889-894. https://doi.org/10.1126/science.1141634

Greenburg, D. L., Lettieri, C. J., & Eliasson, A. H. (2009). Effects of surgical weight loss on measures of obstructive sleep apnea: A meta-analysis. American Journal of Medicine, 122(6), 535-542. https://doi.org/10.1016/j.amjmed.2008.10.037

Issa, F. G., & Sullivan, C. E. (1982). Alcohol, snoring and sleep apnea. Journal of Neurology, Neurosurgery & Psychiatry, 45(4), 353-359. https://doi.org/10.1136/jnnp.45.4.353

Johannsdottir, B., Thorarinsson, F., Thordarson, A., & Magnusson, T. E. (2005). Heritability of craniofacial characteristics between parents and offspring estimated from lateral cephalograms. American Journal of Orthodontics and Dentofacial Orthopedics, 127(2), 200-207. https://doi.org/10.1016/j.ajodo.2003.07.020

Joosten, S. A., O'Driscoll, D. M., Berger, P. J., & Hamilton, G. S. (2014). Supine position related obstructive sleep apnea in adults: Pathogenesis and treatment. Sleep Medicine Reviews, 18(1), 7-17. https://doi.org/10.1016/j.smrv.2013.01.005

Kendzerska, T., Gershon, A. S., Hawker, G., Tomlinson, G., & Leung, R. S. (2014). Obstructive sleep apnea and incident diabetes: A historical cohort study. American Journal of Respiratory and Critical Care Medicine, 190(2), 218-225. https://doi.org/10.1164/rccm.201312-2209OC

Kim, A. M., Keenan, B. T., Jackson, N., Chan, E. L., Staley, B., Poptani, H., ... & Schwab, R. J. (2014). Tongue fat and its relationship to obstructive sleep apnea. Sleep, 37(10), 1639-1648. https://doi.org/10.5665/sleep.4072

Li, K. K., Kushida, C., Powell, N. B., Riley, R. W., & Guilleminault, C. (2000). Obstructive sleep apnea syndrome: A comparison between Far-East Asian and white men. The Laryngoscope, 110(10), 1689-1693. https://doi.org/10.1097/00005537-200010000-00022

Marin, J. M., Carrizo, S. J., Vicente, E., & Agusti, A. G. (2005). Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure. The Lancet, 365(9464), 1046-1053. https://doi.org/10.1016/S0140-6736(05)71141-7

Osorio, R. S., Gumb, T., Pirraglia, E., Varga, A. W., Lu, S. E., Lim, J., ... & de Leon, M. J. (2015). Sleep-disordered breathing advances cognitive decline in the elderly. Neurology, 84(19), 1964-1971. https://doi.org/10.1212/WNL.0000000000001566

Peppard, P. E., Young, T., Palta, M., Dempsey, J., & Skatrud, J. (2000). Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA, 284(23), 3015-3021. https://doi.org/10.1001/jama.284.23.3015

Peppard, P. E., Young, T., Barnet, J. H., Palta, M., Hagen, E. W., & Hla, K. M. (2013). Increased prevalence of sleep-disordered breathing in adults. American Journal of Epidemiology, 177(9), 1006-1014. https://doi.org/10.1093/aje/kws342

Rand, C. M., Berry-Kravis, E. M., Zhou, L., Fan, W., & Weese-Mayer, D. E. (2011). Allele frequency of PHOX2B polyalanine expansion mutation in a cohort of subjects with congenital central hypoventilation syndrome (CCHS). Advances in Experimental Medicine and Biology, 669, 269-273. https://doi.org/10.1007/978-1-4419-5692-7_55

Redline, S., Tishler, P. V., Tosteson, T. D., Williamson, J., Kump, K., Browner, I., ... & Krejci, P. (1995). The familial aggregation of obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine, 151(3), 682-687. https://doi.org/10.1164/ajrccm/151.3_Pt_1.682

Shungin, D., Winkler, T. W., Croteau-Chonka, D. C., Ferreira, T., Locke, A. E., Mägi, R., ... & Mohlke, K. L. (2015). New genetic loci link adipose and insulin biology to body fat distribution. Nature, 518(7538), 187-196. https://doi.org/10.1038/nature14132

Sutherland, K., Vanderveken, O. M., Tsuda, H., Bonsignore, M., Iber, C., Kayamori, F., ... & Cistulli, P. A. (2014). Oral appliance treatment for obstructive sleep apnea: An update. Journal of Clinical Sleep Medicine, 10(2), 215-227. https://doi.org/10.5664/jcsm.3460

Terrill, P. I., Edwards, B. A., Nemati, S., Butler, J. P., Owens, R. L., Eckert, D. J., ... & Sands, S. A. (2015). Quantifying the ventilatory control contribution to sleep apnoea using polysomnography. European Respiratory Journal, 45(2), 408-418. https://doi.org/10.1183/09031936.00062914

Tregear, S., Reston, J., Schoelles, K., & Phillips, B. (2009). Obstructive sleep apnea and risk of motor vehicle crash. Journal of Clinical Sleep Medicine, 5(6), 573-581.

Weese-Mayer, D. E., Berry-Kravis, E. M., Ceccherini, I., Keens, T. G., Loghmanee, D. A., & Trang, H. (2010). An official ATS clinical policy statement: Congenital central hypoventilation syndrome. American Journal of Respiratory and Critical Care Medicine, 181(6), 626-644. https://doi.org/10.1164/rccm.200807-1069ST

Weinberg, S. M., Parsons, T. E., Marazita, M. L., & Maher, B. S. (2013). Heritability of face shape in twins: A preliminary study using 3D stereophotogrammetry and geometric morphometrics. Dentistry 3000, 1(1), 14. https://doi.org/10.5195/d3000.2013.14

Wellman, A., Malhotra, A., Jordan, A. S., Stevenson, K. E., Gautam, S., & White, D. P. (2011). Effect of oxygen in obstructive sleep apnea: Role of loop gain. Respiratory Physiology & Neurobiology, 162(2), 144-151. https://doi.org/10.1016/j.resp.2008.05.019

Wetter, D. W., Young, T. B., Bidwell, T. R., Badr, M. S., & Palta, M. (1994). Smoking as a risk factor for sleep-disordered breathing. Archives of Internal Medicine, 154(19), 2219-2224. https://doi.org/10.1001/archinte.1994.00420190121014

Young, T., Peppard, P. E., & Taheri, S. (2002). Excess weight and sleep-disordered breathing. Journal of Applied Physiology, 99(4), 1592-1599. https://doi.org/10.1152/japplphysiol.00587.2005

---

Related Reading

• obesity and FTO gene
• heart disease genetic risk
• hypertension genetics
• polygenic risk scores